tirzepatide trade names Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research Tirzepatide (Zepbound, Mounjaro): Weight Loss,

The dose escalation journey: what each level feels like Understanding what to expect at each dose level helps you interpret your own before-and-after journey

The use of GLP-1, GIP, and dual/triple receptor agonists, as well as intranasal insulin, requires further evaluation in large clinical trials

Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin

5.5 Long-Term Suppression of Growth in Pediatric Patients VYVANSE is not approved for use and is not recommended in pediatric patients below 6 years of age [see Use in Specific Populations (8.4)]

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists